位置:首页 > 蛋白库 > DUS5_HUMAN
DUS5_HUMAN
ID   DUS5_HUMAN              Reviewed;         384 AA.
AC   Q16690; Q12997; Q5T603;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   03-AUG-2022, entry version 190.
DE   RecName: Full=Dual specificity protein phosphatase 5;
DE            EC=3.1.3.16 {ECO:0000269|PubMed:7961985};
DE            EC=3.1.3.48 {ECO:0000269|PubMed:7961985};
DE   AltName: Full=Dual specificity protein phosphatase hVH3;
GN   Name=DUSP5; Synonyms=VH3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND CATALYTIC ACTIVITY.
RC   TISSUE=Mammary gland;
RX   PubMed=7961985; DOI=10.1016/s0021-9258(18)43965-8;
RA   Ishibashi T., Bottaro D.P., Michieli P., Kelley C.A., Aaronson S.A.;
RT   "A novel dual specificity phosphatase induced by serum stimulation and heat
RT   shock.";
RL   J. Biol. Chem. 269:29897-29902(1994).
RN   [2]
RP   SEQUENCE REVISION.
RA   Bottaro D.P.;
RL   Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=7836374; DOI=10.1074/jbc.270.3.1156;
RA   Kwak S.P., Dixon J.E.;
RT   "Multiple dual specificity protein tyrosine phosphatases are expressed and
RT   regulated differentially in liver cell lines.";
RL   J. Biol. Chem. 270:1156-1160(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 178-384, AND ACTIVE SITE.
RX   PubMed=17078075; DOI=10.1002/prot.21224;
RA   Jeong D.G., Cho Y.H., Yoon T.S., Kim J.H., Ryu S.E., Kim S.J.;
RT   "Crystal structure of the catalytic domain of human DUSP5, a dual
RT   specificity MAP kinase protein phosphatase.";
RL   Proteins 66:253-258(2007).
CC   -!- FUNCTION: Dual specificity protein phosphatase; active with
CC       phosphotyrosine, phosphoserine and phosphothreonine residues. The
CC       highest relative activity is toward ERK1. {ECO:0000269|PubMed:7961985}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10044, ECO:0000269|PubMed:7961985};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:83421; EC=3.1.3.16;
CC         Evidence={ECO:0000269|PubMed:7961985};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:61977; EC=3.1.3.16;
CC         Evidence={ECO:0000269|PubMed:7961985};
CC   -!- INTERACTION:
CC       Q16690; P28482: MAPK1; NbExp=3; IntAct=EBI-7487376, EBI-959949;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family. Non-
CC       receptor class dual specificity subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U15932; AAA64693.2; -; mRNA.
DR   EMBL; U16996; AAB06261.1; -; mRNA.
DR   EMBL; AL355512; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC062545; AAH62545.1; -; mRNA.
DR   CCDS; CCDS7566.1; -.
DR   PIR; I38890; I38890.
DR   RefSeq; NP_004410.3; NM_004419.3.
DR   PDB; 2G6Z; X-ray; 2.70 A; A/B/C=178-384.
DR   PDBsum; 2G6Z; -.
DR   AlphaFoldDB; Q16690; -.
DR   SMR; Q16690; -.
DR   BioGRID; 108180; 52.
DR   IntAct; Q16690; 5.
DR   MINT; Q16690; -.
DR   STRING; 9606.ENSP00000358596; -.
DR   BindingDB; Q16690; -.
DR   ChEMBL; CHEMBL1250380; -.
DR   DEPOD; DUSP5; -.
DR   iPTMnet; Q16690; -.
DR   PhosphoSitePlus; Q16690; -.
DR   BioMuta; DUSP5; -.
DR   DMDM; 215273975; -.
DR   EPD; Q16690; -.
DR   MassIVE; Q16690; -.
DR   MaxQB; Q16690; -.
DR   PaxDb; Q16690; -.
DR   PeptideAtlas; Q16690; -.
DR   PRIDE; Q16690; -.
DR   ProteomicsDB; 61034; -.
DR   Antibodypedia; 18355; 307 antibodies from 27 providers.
DR   DNASU; 1847; -.
DR   Ensembl; ENST00000369583.4; ENSP00000358596.3; ENSG00000138166.6.
DR   GeneID; 1847; -.
DR   KEGG; hsa:1847; -.
DR   MANE-Select; ENST00000369583.4; ENSP00000358596.3; NM_004419.4; NP_004410.3.
DR   UCSC; uc001kzd.4; human.
DR   CTD; 1847; -.
DR   DisGeNET; 1847; -.
DR   GeneCards; DUSP5; -.
DR   HGNC; HGNC:3071; DUSP5.
DR   HPA; ENSG00000138166; Tissue enhanced (esophagus, urinary bladder).
DR   MIM; 603069; gene.
DR   neXtProt; NX_Q16690; -.
DR   OpenTargets; ENSG00000138166; -.
DR   PharmGKB; PA27528; -.
DR   VEuPathDB; HostDB:ENSG00000138166; -.
DR   eggNOG; KOG1716; Eukaryota.
DR   GeneTree; ENSGT00940000159529; -.
DR   HOGENOM; CLU_027074_0_2_1; -.
DR   InParanoid; Q16690; -.
DR   OMA; SYCTFPT; -.
DR   OrthoDB; 1576308at2759; -.
DR   PhylomeDB; Q16690; -.
DR   TreeFam; TF105122; -.
DR   PathwayCommons; Q16690; -.
DR   Reactome; R-HSA-112409; RAF-independent MAPK1/3 activation.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   SignaLink; Q16690; -.
DR   SIGNOR; Q16690; -.
DR   BioGRID-ORCS; 1847; 18 hits in 1077 CRISPR screens.
DR   ChiTaRS; DUSP5; human.
DR   EvolutionaryTrace; Q16690; -.
DR   GeneWiki; DUSP5; -.
DR   GenomeRNAi; 1847; -.
DR   Pharos; Q16690; Tchem.
DR   PRO; PR:Q16690; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q16690; protein.
DR   Bgee; ENSG00000138166; Expressed in lower esophagus mucosa and 182 other tissues.
DR   Genevisible; Q16690; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IBA:GO_Central.
DR   GO; GO:0017018; F:myosin phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016791; F:phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IBA:GO_Central.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; TAS:ProtInc.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0008330; F:protein tyrosine/threonine phosphatase activity; IBA:GO_Central.
DR   GO; GO:0016311; P:dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0001706; P:endoderm formation; IBA:GO_Central.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; TAS:Reactome.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0043409; P:negative regulation of MAPK cascade; IBA:GO_Central.
DR   GO; GO:0035970; P:peptidyl-threonine dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0006470; P:protein dephosphorylation; TAS:ProtInc.
DR   Gene3D; 3.40.250.10; -; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR008343; MKP.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR001763; Rhodanese-like_dom.
DR   InterPro; IPR036873; Rhodanese-like_dom_sf.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; Tyr_Pase_dom.
DR   InterPro; IPR020422; TYR_PHOSPHATASE_DUAL_dom.
DR   Pfam; PF00782; DSPc; 1.
DR   Pfam; PF00581; Rhodanese; 1.
DR   PIRSF; PIRSF000939; MAPK_Ptase; 1.
DR   PRINTS; PR01764; MAPKPHPHTASE.
DR   SMART; SM00195; DSPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SMART; SM00450; RHOD; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   SUPFAM; SSF52821; SSF52821; 1.
DR   PROSITE; PS50206; RHODANESE_3; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50054; TYR_PHOSPHATASE_DUAL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Hydrolase; Nucleus; Protein phosphatase; Reference proteome.
FT   CHAIN           1..384
FT                   /note="Dual specificity protein phosphatase 5"
FT                   /id="PRO_0000094802"
FT   DOMAIN          19..141
FT                   /note="Rhodanese"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00173"
FT   DOMAIN          178..319
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   MOTIF           53..74
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        263
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160,
FT                   ECO:0000269|PubMed:17078075"
FT   VARIANT         154
FT                   /note="E -> D (in dbSNP:rs2282238)"
FT                   /id="VAR_020298"
FT   VARIANT         220
FT                   /note="A -> T (in dbSNP:rs1889566)"
FT                   /id="VAR_059777"
FT   VARIANT         220
FT                   /note="A -> V (in dbSNP:rs1889565)"
FT                   /id="VAR_059778"
FT   VARIANT         322
FT                   /note="P -> L (in dbSNP:rs35101549)"
FT                   /id="VAR_047368"
FT   CONFLICT        9..11
FT                   /note="RQL -> GHV (in Ref. 1; AAA64693)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        71
FT                   /note="A -> R (in Ref. 1; AAA64693)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        105..106
FT                   /note="AR -> F (in Ref. 1; AAA64693)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        220
FT                   /note="A -> M (in Ref. 1; AAA64693, 3; AAB06261 and 5;
FT                   AAH62545)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        382
FT                   /note="T -> Q (in Ref. 1; AAA64693)"
FT                   /evidence="ECO:0000305"
FT   STRAND          180..183
FT                   /evidence="ECO:0007829|PDB:2G6Z"
FT   STRAND          186..190
FT                   /evidence="ECO:0007829|PDB:2G6Z"
FT   HELIX           191..194
FT                   /evidence="ECO:0007829|PDB:2G6Z"
FT   HELIX           197..203
FT                   /evidence="ECO:0007829|PDB:2G6Z"
FT   STRAND          207..210
FT                   /evidence="ECO:0007829|PDB:2G6Z"
FT   STRAND          223..227
FT                   /evidence="ECO:0007829|PDB:2G6Z"
FT   HELIX           239..241
FT                   /evidence="ECO:0007829|PDB:2G6Z"
FT   HELIX           242..254
FT                   /evidence="ECO:0007829|PDB:2G6Z"
FT   STRAND          259..268
FT                   /evidence="ECO:0007829|PDB:2G6Z"
FT   HELIX           269..282
FT                   /evidence="ECO:0007829|PDB:2G6Z"
FT   HELIX           286..296
FT                   /evidence="ECO:0007829|PDB:2G6Z"
FT   HELIX           304..317
FT                   /evidence="ECO:0007829|PDB:2G6Z"
SQ   SEQUENCE   384 AA;  42047 MW;  2E4B2938F886CB4E CRC64;
     MKVTSLDGRQ LRKMLRKEAA ARCVVLDCRP YLAFAASNVR GSLNVNLNSV VLRRARGGAV
     SARYVLPDEA ARARLLQEGG GGVAAVVVLD QGSRHWQKLR EESAARVVLT SLLACLPAGP
     RVYFLKGGYE TFYSEYPECC VDVKPISQEK IESERALISQ CGKPVVNVSY RPAYDQGGPV
     EILPFLYLGS AYHASKCEFL ANLHITALLN VSRRTSEACA THLHYKWIPV EDSHTADISS
     HFQEAIDFID CVREKGGKVL VHCEAGISRS PTICMAYLMK TKQFRLKEAF DYIKQRRSMV
     SPNFGFMGQL LQYESEILPS TPNPQPPSCQ GEAAGSSLIG HLQTLSPDMQ GAYCTFPASV
     LAPVPTHSTV SELSRSPVAT ATSC
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024